A multicentric, post-marketing surveillance to monitor the safety and reactogenicity of GlaxoSmithKline Biologicals hepatitis A vaccine [hepatitis A vaccine inactivated; Havrix] administered in Korean population.
Phase of Trial: Phase IV
Latest Information Update: 12 Nov 2008
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Adverse reactions
- 15 Oct 2008 Actual start date changed from Feb 2005 to Jun 2005 as reported by ClinicalTrials.gov
- 24 Nov 2005 New trial record.